DA LABS Offers The Minoxidil Response Test To Customers Who Have Canceled HIMS / HERS Subscription
(MENAFN- EIN Presswire)
HAIR LOSS: TEST AND RE-GROW WITH EASE.
IRVINE, CA, USA, May 3, 2024 /EINPresswire / -- Many people have terminated their subscription for HIMS / HERS due to the tweet released by the founder and CEO Andrew Dudum . Now is the chance to do it the RIGHT way: take the Minoxidil Response Test to test for responsiveness to Minoxidil.
Information that HIMS / HERS (and all other manufacturers of Minoxidil such as Rogaine, Keeps, Kirkland) has never revealed: Only 30-40% of men and women respond to Minoxidil, the only topical FDA approved ingredient for hair-regrowth.
Why spend 6-9 months before finding out if one responds to Minoxidil with such low odds?
The Minoxidil Response Test (MRT): Most often, users quit using hair re-growth systems due to poor results. The MRT is a revolutionary test aimed at addressing the shortcomings of popular hair re-growth systems. It is a hair sulfotransferase enzyme diagnostic test to measure if one is a responder to Minoxidil. The MRT is based on a decade of scientific research backed by clinical studies published in peer-reviewed medical journals.
Minoxidil: DA Labs offers the Minoxidil 5% strength for men and the 2% strength for women.
Limited Time Offer: DA Labs is announcing the sale of the Minoxidil Response Test (MRT) with a free one-month supply of Minoxidil. For more information and to order, go to: .
For more information on licensing or distribution, please contact ....
Monica Naegle
DA Labs
email us here
Visit us on social media:
Facebook
Instagram
MENAFN03052024003118003196ID1108171992
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.